Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychiatry | 6 | 2023 | 1623 | 0.880 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 1894 | 0.820 |
Why?
|
| Depression | 6 | 2021 | 7268 | 0.770 |
Why?
|
| Mental Disorders | 7 | 2023 | 6447 | 0.700 |
Why?
|
| DNA, Mitochondrial | 2 | 2020 | 794 | 0.670 |
Why?
|
| Telomere | 2 | 2021 | 842 | 0.670 |
Why?
|
| Psychotic Disorders | 2 | 2023 | 2847 | 0.610 |
Why?
|
| Aging | 4 | 2021 | 8349 | 0.500 |
Why?
|
| Primary Prevention | 1 | 2020 | 1161 | 0.440 |
Why?
|
| Life Style | 2 | 2021 | 3730 | 0.440 |
Why?
|
| Hospitals, General | 6 | 2023 | 713 | 0.390 |
Why?
|
| Thyroid Nodule | 3 | 2018 | 738 | 0.300 |
Why?
|
| Cholecalciferol | 2 | 2021 | 498 | 0.290 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3428 | 0.280 |
Why?
|
| DNA Methylation | 1 | 2019 | 4078 | 0.270 |
Why?
|
| Hypothyroidism | 3 | 2018 | 649 | 0.260 |
Why?
|
| Affect | 2 | 2021 | 1494 | 0.230 |
Why?
|
| Referral and Consultation | 6 | 2023 | 3452 | 0.210 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 7259 | 0.180 |
Why?
|
| Clozapine | 1 | 2022 | 493 | 0.170 |
Why?
|
| Depressive Disorder | 2 | 2021 | 3804 | 0.160 |
Why?
|
| Comorbidity | 2 | 2023 | 10435 | 0.150 |
Why?
|
| Aged | 15 | 2022 | 162468 | 0.150 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 562 | 0.140 |
Why?
|
| Dietary Supplements | 3 | 2021 | 3110 | 0.130 |
Why?
|
| Pharmacogenetics | 1 | 2019 | 699 | 0.130 |
Why?
|
| Diagnosis, Differential | 4 | 2023 | 13219 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 623 | 0.120 |
Why?
|
| Epithelium | 1 | 2018 | 1721 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 9596 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 1294 | 0.110 |
Why?
|
| Thyroidectomy | 1 | 2018 | 887 | 0.110 |
Why?
|
| Humans | 23 | 2023 | 715818 | 0.110 |
Why?
|
| Vitamins | 1 | 2020 | 1517 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 5412 | 0.100 |
Why?
|
| Thyroid Gland | 1 | 2018 | 1158 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2022 | 2030 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2020 | 1840 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 23437 | 0.090 |
Why?
|
| Health Surveys | 1 | 2020 | 4036 | 0.090 |
Why?
|
| Vitamin D | 2 | 2021 | 3193 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1738 | 0.080 |
Why?
|
| Middle Aged | 10 | 2021 | 214666 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 3899 | 0.080 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 3062 | 0.080 |
Why?
|
| Carcinoma | 1 | 2018 | 2320 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3035 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2019 | 8075 | 0.070 |
Why?
|
| Male | 12 | 2021 | 350352 | 0.070 |
Why?
|
| Female | 12 | 2022 | 377229 | 0.070 |
Why?
|
| Bipolar Disorder | 1 | 2022 | 5054 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2017 | 2225 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 21795 | 0.060 |
Why?
|
| Exercise | 1 | 2020 | 5427 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2018 | 1059 | 0.060 |
Why?
|
| Paranoid Disorders | 1 | 2022 | 56 | 0.060 |
Why?
|
| Restraint, Physical | 1 | 2023 | 186 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2020 | 6701 | 0.050 |
Why?
|
| Neoplasms | 2 | 2018 | 20528 | 0.050 |
Why?
|
| Polypharmacy | 1 | 2020 | 273 | 0.040 |
Why?
|
| Prescriptions | 1 | 2020 | 347 | 0.040 |
Why?
|
| Fish Oils | 1 | 2021 | 463 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 2018 | 288 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2021 | 11945 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 70879 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2021 | 2677 | 0.030 |
Why?
|
| Primary Health Care | 2 | 2022 | 4522 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 10605 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2018 | 5922 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 2018 | 419 | 0.030 |
Why?
|
| United States | 1 | 2021 | 67910 | 0.030 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 7499 | 0.030 |
Why?
|
| Survival Rate | 2 | 2018 | 13213 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2018 | 72473 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 58326 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 2968 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 2025 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8240 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12460 | 0.020 |
Why?
|
| African Americans | 1 | 2021 | 5003 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4294 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 40032 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11689 | 0.020 |
Why?
|
| Incidence | 1 | 2020 | 20733 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 6270 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13215 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16311 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29007 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23476 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 51317 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 212279 | 0.000 |
Why?
|
Concepts
(91)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_